BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rezaeeyan H, Jaseb K, Alghasi A, Asnafi AA, Saki N. Association between gene polymorphisms and clinical features in idiopathic thrombocytopenic purpura patients. Blood Coagul Fibrinolysis 2017;28:617-22. [PMID: 28654425 DOI: 10.1097/MBC.0000000000000646] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Xu Y, Li J, Yang W, Tang X, Huang B, Liu J, Lin J, Zhang J, Yang W, Li S, Sun F, Deng L, Wang X. A Pooling Genome-Wide Association Study Identifies Susceptibility Loci and Signaling Pathways of Immune Thrombocytopenia in Chinese Han Population. Int J Genomics 2020;2020:7531876. [PMID: 32258092 DOI: 10.1155/2020/7531876] [Reference Citation Analysis]
2 Xu J, Zhang X, Feng S, Zhao N, Hu X, Cheng Y, Wu Y, Zhou L, Tong J, Zheng C. Clinical efficacy of high-dose dexamethasone with sequential prednisone maintenance therapy for newly diagnosed adult immune thrombocytopenia in a real-world setting. J Int Med Res 2021;49:3000605211007322. [PMID: 33840249 DOI: 10.1177/03000605211007322] [Reference Citation Analysis]
3 Abbasi F, Kaydani GA, Tahannezhad Z, Nakhaie M, Asnafi AA, Moradi M. Prevalence of Cytomegalovirus (CMV) and Epstein-Barr Virus (EBV) Subclinical Infection in Patients with Acute Immune Thrombocytopenic Purpura (ITP). Int J Hematol Oncol Stem Cell Res 2021;15:139-44. [PMID: 35082994 DOI: 10.18502/ijhoscr.v15i3.6843] [Reference Citation Analysis]
4 Wang J, Wang B, Sun Z, Xue K. Therapeutic effects of rituximab combined with cyclophosphamide on refractory idiopathic thrombocytopenic purpura. Exp Ther Med 2019;17:2137-42. [PMID: 30867701 DOI: 10.3892/etm.2019.7196] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Ghanavat M, Ebrahimi M, Rafieemehr H, Maniati M, Behzad MM, Shahrabi S. Thrombocytopenia in solid tumors: Prognostic significance. Oncol Rev 2019;13:413. [PMID: 31205603 DOI: 10.4081/oncol.2019.413] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
6 Asnafi AA, Mohammadi MB, Rezaeeyan H, Davari N, Saki N. Prognostic significance of mutated genes in megakaryocytic disorders. Oncol Rev 2019;13:408. [PMID: 31410247 DOI: 10.4081/oncol.2019.408] [Reference Citation Analysis]